Your Article Summary
See Latest ArticlesNewer therapies for vasculitis
Best Practice & Research: Clinical Rheumatology, 07/01/09
Hiemstra TF et al. - B-cell depletion with rituximab is currently attracting most attention with good success rates in small studies of refractory disease. The treatment of vasculitis in the future will become more complex with a wider range of available treatments; their optimal combination, sequencing and tailoring to the individual clinical situation will place unique demands on those delivering vasculitis services.
Related Articles
European League Against Rheumatism/European Vasculitis Study Group recommendations for the management of vasculitis
Current Opinion in Rheumatology, 10/16/09
Relevance Score: 92%
Resolution of anti-neutrophil cytoplasmic antibody-associated vasculitis after resection of gastric cancer
Modern Rheumatology, 10/19/09
Relevance Score: 91%
Progress Towards a Core Set of Outcome Measures in Small-vessel Vasculitis. Report from OMERACT 9
Journal of Rheumatology, 10/20/09
Relevance Score: 89%
Cutaneous vasculitis induced by TNF inhibitors: a report of three cases
Modern Rheumatology, 10/16/09
Relevance Score: 88%
Analysis of T-cell receptor usage in myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis
Clinical and Experimental Nephrology, 10/09/09
Relevance Score: 88%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Hypocomplementemic urticarial vasculitis syndrome
Current Rheumatology Reports, 12/03/09
ALO-01 (Morphine Sulfate and Naltrexone Hydrochloride) Extended-Release Capsules in the Treatment of Chronic Pain of Osteoarthritis of the Hip or Knee: Pharmacokinetics, Efficacy, and Safety
The Journal of Pain, 12/02/09
The effect of methotrexate on cardiovascular disease in patients with rheumatoid arthritis: A systematic literature review
Rheumatology, 12/01/09
Today in Vasculitic Syndromes...keeping you current
Receive free subspecialty "5-minute updates" via email
Risk factors for treatment failures in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis
Current Rheumatology Reports, 12/03/09
Systemic vasculitis in childhood
Current Rheumatology Reports, 12/03/09
Hypocomplementemic urticarial vasculitis syndrome
Current Rheumatology Reports, 12/03/09